PlainPill

Melanotan Ii vs NMN for skin & hair

Short answer: For skin & hair, more users report improvement with NMN — 100% of 14 reports, versus 88% of 84 for Melanotan Ii.

Melanotan Ii has 1 meta-analyses and 1 randomized trials on PubMed; NMN has 11 and 17.

Based on 186 reports about Melanotan Ii and 366 about NMN. Not medical advice.

Melanotan Ii
Peptide
NMN
Supplement
Users say it helped60%helped115 reports · high confidence61%helped113 reports · high confidence
Verdict
Mixed
Mostly positive
ResearchBResearch: ModerateAResearch: Strong
Meta-analyses / RCTs1 / 111 / 17
Mainly used for
Skin & hair
% reporting improvement
88% (84)100% (14)
Energy
% reporting improvement
—92% (77)
Libido
% reporting improvement
96% (48)100% (2)
Sleep
% reporting improvement
0% (4)65% (20)
Performance
% reporting improvement
100% (5)100% (16)
Common side effectsnausea, flushing, freckles, molesinsomnia, jitteriness, drowsiness, elevated blood
Typical dose reportedNot listed1 g / daily
Melanotan Ii
Latest review conclusion

Almost all studies are in the preclinical phase. There are currently no effective clinical treatments for MC4R-deficient obese patients, although MC4R agonists are being developed and are entering phase I and II trials.

Int J Obes (Lond), 2014 ↗
What a user said
“I've found that getting sun within 3-12 hours will produce the desired result.”
Full Melanotan Ii profile →
NMN
Latest review conclusion

Overall, NAD⁺ augmentation shows clear biological activity, but clinical effectiveness for anti-aging or wellness outcomes remains inconclusive. Larger, well-designed randomized trials with longer follow-up and prespecified clinically meaningful endpoints are needed, particularly for parenteral approaches.

Ageing Res Rev, 2026 ↗
What a user said
“I've been using NMN for 3 years now, and I had great results with it along with many other supplements. I'm 47 and I look a lot younger and healthier than when I first started NMN.”
Full NMN profile →

Related comparisons

Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate